Finnrick - Ensuring Safe and Transparent Supply Chain
Oasis Peptides

Oasis Peptides
Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP antagonist) from Oasis Peptides between 14 Jan 2025 and 13 Feb 2025. Tests score average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).

Finnrick Rating™
B
GOOD
Oasis Peptides
Tirzepatide
Tested 6 Samples
Last test 13 Feb 2025

Take Action

Mail in a Sample

We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.

Tirzepatide is also available from top-rated vendors:

All Tirzepatide tests from Oasis Peptides

Samples are tested in commercial labs

Tests Count

6

Scores

AVG6.1MIN5.2MAX6.8

Last

13 Feb 2025

First

14 Jan 2025
Quantity
Test Date
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
13 Feb 20255.810mg10.737mg+7.4%99.31%(no batch ID)Black Label / White CapLab CFinnrick
13 Feb 20255.910mg10.766mg+7.7%99.37%(no batch ID)Black Label / White CapLab CFinnrick
13 Feb 20256.55mg5.332mg+6.6%99.53%(no batch ID)Black Label / Blue CapLab CFinnrick
13 Feb 20256.85mg5.276mg+5.5%99.49%(no batch ID)Black Label / Blue CapLab CFinnrick
23 Jan 20256.15mg5.300mg+6.0%99.22%(no batch ID)(no data)Lab BFinnrick
14 Jan 20255.25mg5.414mg+8.3%99.15%(no batch ID)(no data)Lab AFinnrick